The following is an edited excerpt.
Synthetic biology has advanced in leaps and bounds in recent years, with innovations ranging from re-engineered genomes to improved crop strains and DNA as a data storage device. The latest game-changer comes in the form of next-generation gene synthesis, which delivers highly accurate constructs at significantly lower prices and in far greater numbers than has been possible to date.
To learn more, GEN sat down with some of the founders and advisors of Gen9, the Cambridge, MA-based company that has commercialized this high-throughput gene synthesis technology.
Share this article
Read the full post here: Next-Gen Gene Synthesis Opens a World of New Possibilities
